Open access
Aug 2026
Genomic landscape and therapeutic implications of Anaplastic Lymphoma Kinase fusion-positive colorectal cancer
These findings support comprehensive genomic profiling to identify ALK fusions in CRC, which may inform the use of ALK-directed therapies, and highlight the frequent co-occurrence of MSI-high disease within this subgroup.
Xuan-Yi Li, Faiza Yasin, D. Pavlick et al.
· The Oncologist · 0 citations